Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women.

about

Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women.

Item

http://www.wikidata.org/entity/Q46917183

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Estrogen-progestin use and bre ...... erweight postmenopausal women.

@en

Estrogen-progestin use and bre ...... erweight postmenopausal women.

@nl

type

Item

label

Estrogen-progestin use and bre ...... erweight postmenopausal women.

@en

Estrogen-progestin use and bre ...... erweight postmenopausal women.

@nl

prefLabel

Estrogen-progestin use and bre ...... erweight postmenopausal women.

@en

Estrogen-progestin use and bre ...... erweight postmenopausal women.

@nl

P1476

Estrogen-progestin use and bre ...... erweight postmenopausal women.

@en

P2093

Elinborg J Olafsdottir

http://www.w3.org/2001/XMLSchema#string

Jon G Jonasson

http://www.w3.org/2001/XMLSchema#string

Lara G Sigurdardottir

http://www.w3.org/2001/XMLSchema#string

Laufey Tryggvadottir

http://www.w3.org/2001/XMLSchema#string

Olof J Kjartansdottir

http://www.w3.org/2001/XMLSchema#string

P2860

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome

Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status

Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

Data quality at the Icelandic Cancer Registry: comparability, validity, timeliness and completeness.

Menopausal hormone therapy and subsequent risk of specific invasive breast cancer subtypes in the California Teachers Study.

Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women's Health Initiative Randomized Trial.

Breast cancer and hormone-replacement therapy in the Million Women Study.

Menopausal hormone therapy and cancer: changing clinical observations of target site specificity.

P2888

s10549-017-4171-2

P304

363-373

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-017-4171-2

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

163

http://www.w3.org/2001/XMLSchema#string

P50

Giske Ursin

P577

2017-03-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28281022

http://www.w3.org/2001/XMLSchema#string

P921

Adipositas